H.R. 7970 · 119th Congress · Crime and Law Enforcement

STOP Nitazenes Act

Permanently places nitazenes in schedule I of the Controlled Substances Act. AI-read

In committee535 words Introduced Mar 18, 2026 · Latest action Jul 21, 2026

How far it has goneStage 2 of 6
  1. IntroducedMar 18, 2026 Done
  2. CommitteeReferred to 2 committees Current stage
  3. House floorNot yet Not reached yet
  4. Senate floorNot yet Not reached yet
  5. Chambers agreeNot yet Not reached yet
  6. PresidentNot yet Not reached yet

What it does

This bill permanently places nitazenes as a class into schedule I of the Controlled Substances Act. Nitazenes are synthetic opioids similar to fentanyl that can be as potent or more potent than fentanyl. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act.

Congressional Research Service · summary of “Introduced in House” version · Mar 18, 2026

Who lobbies on it

1 organization · 1 filing · Q1 2026–Q3 2026

See which of this bill’s sponsors and cosponsors got money from American Medical Association’s PAC → Pro

One square per quarter since introduction, oldest left. Filled = named it that quarter.

  1. American Medical Association 1 of 3 quarters
    “H.R.1266 - Combating Illicit Xylazine Act, all provisions H.R.1561 - ALERT Communities Act, all provisions H.R.2004 - Tylers Law, all provisions H.R.7970 - STOP Nitazenes Act, all provisions H.R.7994 - HERO Act, all provisions Comment Letter: [2026-11602] HHS Request for Comment on Chronic Disease of Addiction Chronic…”

    $17.6M lobbying spend in 2026 to date, all issuesQ2 2026 filing

Organizations that named H.R. 7970 in a quarterly lobbying report. Covers organizations with a PAC on file; reports from organizations without one aren’t loaded yet. Spend is the organization’s total across all issues: reports don’t split spending by bill. “Gave to” means the organization’s PAC gave to the member’s campaign in the 2025–26 cycle, net of refunds; it doesn’t mean the money was about this bill. Organizations may lobby for, against, or to change a bill; filings don’t say which. Source: Senate lobbying disclosures (LD-2) from lda.gov; PAC gifts from FEC filings; quotes are word for word from the “specific lobbying issues” field; where a filing lists many bills, the quote starts where it names this one.

Actions

8 actions · newest first
  1. Jul 21, 2026Ordered to be Reported in the Nature of a Substitute by the Yeas and Nays: 28 - 21.
  2. Jul 21, 2026Committee Consideration and Mark-up Session Held
  3. Jul 20, 2026Committee Consideration and Mark-up Session Held
  4. Jun 25, 2026Forwarded by Subcommittee to Full Committee by Voice Vote.
Show all 8 actionsShow fewer
  1. Jun 25, 2026Subcommittee Consideration and Mark-up Session Held
  2. Mar 18, 2026Referred to the Subcommittee on Health.
  3. Mar 18, 2026Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  4. Mar 18, 2026Introduced in House